NYSE · HCA
HCA Healthcare, Inc.
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
Loading market information…
NASDAQ · ENSG · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
The Ensign Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
The Ensign Group, Inc.’s forward annual dividend is $0.26 per share, paid quarterly. The forward yield is 0.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
The Ensign Group, Inc.’s next earnings report is currently expected on Feb 3, 2027, with estimated earnings per share of $2.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow The Ensign Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 24, 2025 | $1.59+2.58% vs estimate | $1.23B+0.65% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | $1.52+2.01% vs estimate | $1.17B+0.06% vs estimate |
|---|
| Q4 2024 | Feb 5, 2025 | $1.49+1.36% vs estimate | $1.13B+0.26% vs estimate |
|---|
THE ANALYST VIEW
13 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 4 contributors · Median target $221.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$478.08+$14.86 (+3.21%)
HCA Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
$131.49+$9.41 (+7.7%)
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$49.68+$0.62 (+1.26%)
PACS Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.39% below the high.
$541.92+$8.56 (+1.6%)
Chemed Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.61% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$10.27+$0.29 (+2.91%)
Brookdale Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.91% below the high.
$42.48+$0.32 (+0.76%)
The Pennant Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.14% below the high.
